Cypress Asset Management Inc. TX trimmed its stake in CVS Health Corp (NYSE:CVS) by 17.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,460 shares of the pharmacy operator’s stock after selling 3,990 shares during the period. Cypress Asset Management Inc. TX’s holdings in CVS Health were worth $1,411,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CVS. Wealthcare Advisory Partners LLC increased its holdings in CVS Health by 330.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 991 shares during the period. Fieldpoint Private Securities LLC increased its holdings in CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,000 shares during the period. Arcadia Investment Management Corp MI increased its holdings in CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after purchasing an additional 726 shares during the period. MPS Loria Financial Planners LLC acquired a new stake in CVS Health in the second quarter valued at $119,000. Finally, Cerebellum GP LLC acquired a new stake in CVS Health in the fourth quarter valued at $130,000. Institutional investors and hedge funds own 84.12% of the company’s stock.
In related news, EVP Helena Foulkes sold 19,965 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total value of $1,418,313.60. Following the transaction, the executive vice president now owns 65,072 shares of the company’s stock, valued at approximately $4,622,714.88. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Lisa Bisaccia sold 29,445 shares of the firm’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the transaction, the executive vice president now directly owns 15,556 shares in the company, valued at approximately $1,166,700. The disclosure for this sale can be found here. Company insiders own 0.61% of the company’s stock.
Shares of CVS Health Corp (NYSE CVS) opened at $68.25 on Wednesday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52. The company has a market capitalization of $70,012.85, a PE ratio of 10.55, a PEG ratio of 1.14 and a beta of 1.03. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.00.
CVS Health (NYSE:CVS) last issued its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.88 by $0.04. The company had revenue of $48.39 billion during the quarter, compared to the consensus estimate of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period last year, the business posted $1.71 EPS. analysts anticipate that CVS Health Corp will post 6.37 earnings per share for the current year.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.